Analyst Reco. Edwards Lifesciences Corporation Sao Paulo

Equities

E1WL34

BRE1WLBDR000

Market Closed - Sao Paulo Other stock markets 15:16:09 2024-05-31 EDT			5-day change	1st Jan Change
112.8 ^BRL	+0.61%		-3.42%	+21.18%

05-23	Some of the biggest splits in Corporate America	RE
05-22	Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98	05-22	MT
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86	05-14	MT
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	05-13	MT
Barclays Adjusts Edwards Lifesciences Price Target to $101 From $100	05-07	MT
Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing	05-01	MT
Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing	04-30	MT
Bernstein Adjusts Price Target on Edwards Lifesciences to $73 From $72	04-29	MT
Evercore ISI Adjusts Price Target on Edwards Lifesciences to $89 From $92	04-26	MT
Stifel Adjusts Price Target on Edwards Lifesciences to $85 From $83	04-26	MT
Wells Fargo Adjusts Price Target on Edwards Lifesciences to $99 From $94	04-26	MT
UBS Adjusts Edwards Lifesciences Price Target to $95 From $92, Maintains Neutral Rating	04-26	MT
Piper Sandler Adjusts Price Target on Edwards Lifesciences to $88 From $85	04-26	MT
Canaccord Genuity Trims Price Target on Edwards Lifesciences to $85 From $86	04-26	MT
Baird Adjusts Edwards Lifesciences Price Target to $102 From $100	04-17	MT
Leerink Partners Adjusts Edwards Lifesciences' Price Target to $93 From $96, Keeps Market Perform Rating	04-17	MT
ANALYST RECOMMENDATIONS : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca	04-16
Zacks Investment Research Adjusts Price Target on Edwards Lifesciences to $95 From $97	04-15	MT
Truist Securities Adjusts Edwards Lifesciences Price Target to $105 From $97, Buy Rating Kept	04-15	MT
RBC Raises Price Target on Edwards Lifesciences to $101 From $95, Keeps Outperform Rating	04-15	MT
Mizuho Securities Adjusts Price Target on Edwards Lifesciences to $105 From $95, Maintains Buy Rating	04-11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 11:25 am